IDIX @ $3.93 <<<"well, you've certainly hit the nail on the head so far...">>>
Another thing about IDIX - an investment here pins its future on the HiV market. In reality though, HiV is nowhere the medical problem it used to be, and is largely controllable. Plus the market is hugely competitive, and is dominated by drug cocktails. This phase one candidate is one of the longest shots ever. And apart from that, what else is in the pipeline ? Not much.
Sell.